Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.6M Buy
197,671
+195,389
+8,562% +$66.9M 0.3% 75
2026
Q1
$803K Sell
2,282
-49,080
-96% -$17.5M 0.01% 494
2025
Q4
$16.8M Sell
51,362
-148,956
-74% -$47.3M 0.11% 133
2025
Q3
$56.5M Buy
200,318
+8
+0% +$2.32K 0.4% 57
2025
Q2
$55.9M Buy
200,310
+19,411
+11% +$5.5M 0.49% 43
2025
Q1
$56.4M Buy
180,899
+177,777
+5,694% +$52.5M 1.08% 25
2024
Q4
$814K Buy
3,122
+1,448
+86% +$430K 0.01% 270
2024
Q3
$539K Buy
+1,674
New +$548K 0.01% 293
2024
Q1
Sell
-11,290
Closed -$3.25M 496
2023
Q4
$3.25M Buy
+11,290
New +$3.08M 0.13% 118
2023
Q1
Sell
-1,665
Closed -$437K 261
2022
Q4
$437K Buy
+1,665
New +$446K 0.06% 185

Other funds holding AMGN

Marex Group's AMGN Position: Q2 2026 in Review

Marex Group increased its Amgen (AMGN) stake by 8,562% in Q2 2026, buying an estimated $66.9M and bringing the position to 197,671 shares worth $71.6M. The position accounts for 0.3% of the portfolio, ranked #75.

Marex Group first reported a position in AMGN in Q4 2022 and has held it in 10 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Marex Group held 197,671 shares of Amgen worth $71.6M as of Q2 2026.
  • Marex Group bought 195,389 Amgen shares in Q2 2026, an estimated $66.9M.
  • Amgen made up 0.3% of Marex Group's portfolio in Q2 2026, its #75 holding.
  • Marex Group first reported a position in Amgen in Q4 2022 and has held it in 10 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.